Showing results (21-30 of 96) with videos related to
Sort By:
Pageof 10
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella MateraCurrent Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara RinaldiNature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.The Journal of Pharmacology and Experimental Therapeutics|February 7, 2015
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and coughRaj Makwana, Radhakrishnan Venkatasamy, Domenico Spina, et al.Handbook of Experimental Pharmacology|December 12, 2019
Perspectives of Pharmacology over the Past 100 YearsJames E Barrett, Clive Page, Martin C MichelTrends in Pharmacological Sciences|September 28, 2007
Treating systemic effects of COPDMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.British Journal of Pharmacology|January 25, 2006
Mechanism of adenosine-induced airways obstruction in allergic guinea pigsSandra Keir, Victoria Boswell-Smith, Domenico Spina, et al.Pharmaceutical Patent Analyst|January 19, 2019
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary diseaseMario Cazzola, Clive Page, Luigino Calzetta, et al.Pulmonary Pharmacology & Therapeutics|November 27, 2004
Mechanisms of acute coughClive Page, Sandra M Reynolds, Auralyn J Mackenzie, et al.British Journal of Pharmacology|May 20, 2025
Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airwaysPaola Rogliani, Clive Page, Francesco Facciolo, et al.Pageof 10